
Earnings This Week: US banks, UnitedHealth and Delta Air Lines
Find out what to expect from the stocks due to report earnings this week.
Share this:
Earnings calendar: July 10 – 14
Earnings season is here! As usual, it will begin with results out from major US banks with JPMorgan, Wells Fargo and Citigroup, which are all due to report at the end of the week, alongside financial giant BlackRock and health insurer UnitedHealth. We also have beverage behemoth Pepsi and Delta Air Lines scheduled in on Thursday.
Taiwanese semiconductor firm TSMC will report monthly sales for June ahead of results out next week.
The UK calendar is quiet, headlined by full year results out from fashion house Burberry.
| Monday July 10 | Friday July 14 |
| TSMC June sales | JPMorgan Q2 |
| Tuesday July 11 | Citigroup Q2 |
| N/A | Wells Fargo Q2 |
| Wednesday July 12 | BlackRock Q2 |
| DNB Bank H1 | State Street Q2 |
| AEON Q1 | UnitedHealth Q2 |
| Thursday July 13 | Burberry Q1 |
| Pepsi Q2 | |
| Delta Air Lines Q2 | |
| ConAgra Foods Q4 | |
| Fastenal Q2 | |
| Aker BP H1 |
US bank stocks: Q2 earnings preview
JPMorgan, Wells Fargo and Citigroup will kick off earnings season for the banking industry at the end of the week, with peers to follow the week after. The largest US banks have been given a clean bill of health after passing the annual stress test last month, which carried extra significance in wake of the banking crisis that erupted in March and led to the collapse of several banks. That has provided some much-needed support and allowed them to raise dividends, although share buybacks could remain limited as they brace for tighter capital requirements to be introduced. It will be a mixed-bag of results, with those most exposed to rising interest rates set to outperform those geared more toward activities like trading and investment banking, where conditions remain tough. Deposits and loan growth will remain under the spotlight, and keep an eye on rising provisions as the sector becomes more pessimistic about the economic outlook. JPMorgan, Wells Fargo and Citigroup have defied the broader downturn seen in bank stocks this year but have still significantly underperformed the wider market with their mild gains, while confidence is yet to return to the regional banking sector with the sector still down some 27% this year. The outlook is becoming more challenging in the second half as persistently high inflation and rising interest rates continue to raise the risk of a recession and regulatory threats build. You can find out everything you need to know, from dates and consensus estimates to technical analysis on JPMorgan and Bank of America, in our US Banks Q2 Earnings Preview.
US bank stocks: Q2 earnings preview
JPMorgan, Wells Fargo and Citigroup will kick off earnings season for the banking industry at the end of the week, with peers to follow the week after. The largest US banks have been given a clean bill of health after passing the annual stress test last month, which carried extra significance in wake of the banking crisis that erupted in March and led to the collapse of several banks. That has provided some much-needed support and allowed them to raise dividends, although share buybacks could remain limited as they brace for tighter capital requirements to be introduced. It will be a mixed-bag of results, with those most exposed to rising interest rates set to outperform those geared more toward activities like trading and investment banking, where conditions remain tough. Deposits and loan growth will remain under the spotlight, and keep an eye on rising provisions as the sector becomes more pessimistic about the economic outlook. JPMorgan, Wells Fargo and Citigroup have defied the broader downturn seen in bank stocks this year but have still significantly underperformed the wider market with their mild gains, while confidence is yet to return to the regional banking sector with the sector still down some 27% this year. The outlook is becoming more challenging in the second half as persistently high inflation and rising interest rates continue to raise the risk of a recession and regulatory threats build. You can find out everything you need to know, from dates and consensus estimates to technical analysis on JPMorgan and Bank of America, in our US Banks Q2 Earnings Preview.
UnitedHealth stock: Q2 earnings preview
UnitedHealth and other health insurers have significantly underperformed the wider market this year, with the stock down 9.5% despite expectations that it can deliver record earnings in 2023. That is because markets are worried about the outlook. CFO John Franklin Rex sparked a selloff in the sector last month when he warned that older people are getting more medical procedures that were delayed during the Covid-19 pandemic, sparking fears that more claims will be made and hurt profitability. UnitedHealth raised its outlook back in April, when it said it is aiming for annual adjusted EPS of $24.50 to $25.00, with analysts currently leaning toward the upper-end of that range and believing it will rise almost 12% from last year. The key question is whether this rise in surgeries will impact that guidance and lead to profitability being eroded this year and next. Wall Street forecasts UnitedHealth’s revenue will rise 13% in the second quarter to $90.95 billion and are looking for adjusted EPS to rise 8.4% to $6.04. We may also hear more about its deal to buy Amedisys as part of its push into the home healthcare market, although there is still a risk of a rival bidder coming in.
Pepsi stock: Q2 earnings preview
Pepsi’s array of beverages and snacks as well as its geographical reach around the world has allowed it to flex pricing power in the inflationary environment. It has continued to raise raising prices and this has only recently started to impact volumes, alongside softer consumer spending. That has also allowed it to keep margins largely steady. Wall Street forecasts Pepsi will deliver 7.2% year-on-year revenue growth to $21.7 billion in the second quarter and are looking for organic revenue growth of 9.8%. Topline growth will be led by North and South America, supplemented by Europe. That will counter softer conditions in Asia and Africa. Core EPS is expected to be up 5.3% from last year at $1.96 – but it is worth noting that Pepsi has beaten expectations for 17 consecutive quarters! Pepsi raised its full year outlook back in April and is now targeting annual organic revenue growth of 8% and for core EPS to rise 9%. Analysts back its sales target but only see 7.6% growth in earnings at present.
Delta Air Lines stock: Q2 earnings preview
This is a crucial year for Delta Air Lines considering markets not only believe this will be the first year earnings will return back above pre-pandemic levels but that they will hit an all-time record high. The fact Delta Air Lines raised its annual outlook when it held its investor day in late June, saying it would hit the top-end of forecasts for operating margins (10% to 12%) and earnings per share ($5 to $6) while bumping up its free cashflow target to $3 billion from $2 billion, reinforces those hopes. Wall Street forecasts the airline will report 17% year-on-year growth in revenue in the second quarter to $14.4 billion – which would be a quarterly record! Adjusted EPS is also forecast to hit a new high and jump 65% to $2.37. Higher fares and lower fuel costs will help deliver the impressive growth, although rising wages across the industry will counter this. The rosy landscape has sent Delta Air Lines stock flying over the past month, taking year-to-date gains to 45%. It has outperformed its US rivals and climbed to a 27-month high before pulling back this week, with the RSI in deep overbought territory. Delta Air Lines may struggle to keep up the momentum this week without a positive surprise, and that is less likely given it has already raised its outlook. All seems well now that the airline industry is posting record figures after recovering from the pandemic and Delta Air Lines has said it expects profits and cashflow to improve further in 2024, suggesting it should remain on the right trajectory for some time. However, there are risks ahead as inflation and rising rates continue to eat away at consumer’s finances while simultaneously raising the risks of a recession. Delta Air Lines has said it is confident given high-income travellers generate around 75% of all spending on air travel and because travel is a high priority for wealthier households.
Burberry share price: Q1 earnings preview
This week’s update will focus exclusively on how sales have performed in the first quarter and the outlook for the remainder of the year. Analysts forecast it will report retail revenue of £588.2 million and same-store sales growth of 18.3%. Asia remains key for growth and much of its progress will be determined by how demand fares as the Chinese economy rebounds, with its recovery having been much slower than hoped so far. Asia Pacific same store sales are forecast to be up 34.5% in the first quarter, with sales in mainland China estimated to be up 60%! EMEIA (dominated by Europe, the US and the Middle East) is also powering ahead with sales forecast to be up over 20%, while the Americas remains under pressure and is expected to see a 9.2% decline. Burberry’s goal is to deliver high-single digit CAGR growth in revenue versus what it delivered in 2020 and deliver an adjusted operating margin of ‘around 20%’ over the full year. Markets believe it can achieve its sales target and forecast a full year margin of 19.6%. The stock needs a catalysts considering it has been stuck in decline since late April, down 2% since the start of 2023 and recently hit fresh 2023-lows. A sales beat or an upgraded outlook would therefore be welcome. The addition of new chief creative officer Daniel Lee in February could add momentum this year. With all this in mind, Burberry is currently unloved by the markets and trades at a sizeable 30% discount compared to its peers with a forward price-to-earnings ratio of 16.2x.
How to trade stocks
You can trade stocks with City Index in just four easy steps:
- Open a City Index account, or log-in if you’re already a customer.
- Search for the stock you want in our award-winning platform
- Choose your position and size, and your stop and limit levels
- Place the trade
Or you can practice trading risk-free by signing up for our Demo Trading Account.
Latest market news
View more newsThe complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

RBA delivers 25bp hike, Bullock now the main event
The RBA delivered the expected 25bp hike, but Bullock’s press conference now looms as the bigger volatility risk for AUD/USD and the ASX 200.

Gold outlook: XAU/USD hammered, stretched and vulnerable to a sharp rebound
Gold is getting hammered for solid fundamental reasons, but history suggests extreme four-hourly oversold conditions can produce violent countertrend rallies.

Gold forecast: Rising yields become too hot for gold, but the outlook is far from bearish
Gold and silver prices took a plunge today, with the former down 3% and the latter falling some 5% by mid European session, before bouncing off their lows. The losses come after the metals remained largely supported until last week, despite the big dollar rally and surging bond yields as we have seen in recent weeks. But it simply got too much, and the metals succumbed to pressure today.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.




